AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,932,000 | -35.0% | 871,200 | -8.7% | 0.01% | -36.4% |
Q2 2021 | $15,270,000 | -10.8% | 953,776 | -0.4% | 0.01% | -15.4% |
Q1 2021 | $17,118,000 | +97.3% | 957,898 | +49.1% | 0.01% | +85.7% |
Q4 2020 | $8,677,000 | +16.4% | 642,243 | +1.4% | 0.01% | +16.7% |
Q3 2020 | $7,453,000 | -20.6% | 633,193 | -0.5% | 0.01% | -25.0% |
Q2 2020 | $9,390,000 | +14.3% | 636,175 | +4.5% | 0.01% | -11.1% |
Q1 2020 | $8,217,000 | -43.7% | 608,695 | -0.7% | 0.01% | -25.0% |
Q4 2019 | $14,583,000 | +86.3% | 612,751 | +50.4% | 0.01% | +71.4% |
Q3 2019 | $7,829,000 | – | 407,330 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |